4Minderhoud IM,Oldenburg B, van Dam PS, et al. Highprevalence of fatigue in quiescent inflammatory bowel dis-ease is not related to adrenocortical insufficiency[J]. Am JGastroenterol,2003,98(5) : 1088-1093.
6Abe Y,Murano M,Murajio N. Simvastatin attenuates in-testinal fibrosis independent of the anti-inflammatoryeffect by promoting fibroblast/myofibroblast apoptosis inthe regeneration/healing process from TNBS-induced co-Dig Dis Sci,2012,57(2) :335-344.
8Han EC> Cho SB, Ahn KJ,et al. Expression of pro-inflam-matory protein S100A12(EN-RAGE) in Behcet7 s diseaseand its association with disease activity : a pilot study [J].Ann Dermatol,2011,23(3) :313-320.
7Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 1976, 70: 439-444.
8Jeejeebhoy KN. The many faces of malnutrition in Crohn disease. Am J Clin Nutr, 1998, 67: 819-820.
9Bannerjee K, Camacho-HUbner C, Babinska K, et al. Antiinflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr, 2004, 38: 270-275.
10McClave SA, Sexton LK, Spain DA, et al. Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med, 1999,27 : 1252-1256.
